logo
How to delete your 23andMe data

How to delete your 23andMe data

Yahoo15 hours ago

DNA testing service 23andMe filed for bankruptcy protection in March, sparking concerns about what could happen to the genetic data of the company's 15 million customers.
Pharmaceutical giant Regeneron announced in May that it was buying the genetic testing company for $256 million following a bankruptcy auction. While the company has said it will maintain 23andMe's privacy practices, it also stated that it would use the 23andMe data to aid the discovery of new drugs. More recently, TTAM Research Institute (a nonprofit led by 23andMe's co-founder and former CEO Anne Wojcicki) was announced as the winner in a new round of bidding.
When 23andMe filed for bankruptcy, security experts and lawmakers cautioned customers to take action to protect their data. This week, 23andMe's interim chief executive Joseph Selsavage told lawmakers that 1.9 million people, or about 15% of its customer base, have requested to delete their genetic data. Selsavage shared the number during a House Oversight Committee hearing where lawmakers scrutinized the company's sale.
Also this week, more than two dozen states sued 23andMe to challenge the sale of its customers' private data. The states argue the company must obtain explicit consent from its customers before selling their data.
If you're one of the 15 million people who shared their DNA with 23andMe, we've outlined the steps you can take to protect yourself. While you can't delete all your 23andMe data, there are some things you can control.
To delete your data from 23andMe, you need to log in to your account and then follow these steps:
You will then receive an email from 23andMe with a link that will allow you to confirm your deletion request.
You can choose to download a copy of your data before deleting it.
There is an important caveat, as 23andMe's privacy policy states that the company and its labs 'will retain your Genetic Information, date of birth, and sex as required for compliance with applicable legal obligations.'
The policy continues: '23andMe will also retain limited information related to your account and data deletion request, including but not limited to, your email address, account deletion request identifier, communications related to inquiries or complaints and legal agreements for a limited period of time as required by law, contractual obligations, and/or as necessary for the establishment, exercise or defense of legal claims and for audit and compliance purposes.'
This essentially means that 23andMe may keep some of your information for an unspecified amount of time.
If you previously opted to have your saliva sample and DNA stored by 23andMe, you can change this setting.
To revoke your permission, go into your 23andMe account settings page and then navigate to Preferences.
In addition, if you previously agreed to 23andMe and third-party researchers using your genetic data and sample for research, you can withdraw consent from the Research and Product Consents section in your account settings.
While you can reverse that consent, there's no way for you to delete that information.
Once you have requested the deletion of your data, it's important to check in with your family members and encourage them to do the same because it's not just their DNA that's at risk of sale — it also affects people they are related to.
And while you're at it, it's worth checking in with your friends to ensure that all of your loved ones are taking steps to protect their data.
This story originally published on March 25 and was updated June 11 with new information.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

How the Brooklyn Nets can help the Boston Celtics this NBA offseason
How the Brooklyn Nets can help the Boston Celtics this NBA offseason

Yahoo

time9 minutes ago

  • Yahoo

How the Brooklyn Nets can help the Boston Celtics this NBA offseason

Can the Brooklyn Nets help the Boston Celtics this NBA offseason? As the team in the league with the largest payroll that is also over the second apron long enough to incur the worst penalties mandated by the collective bargaining agreement (CBA), the Celtics are staring at being hit with a potentially historic payroll and tax bill on top of the punitive team building penalties the CBA will dole out on Boston. Enter the Nets, who are the only team in the Association that is going to have the sort of cap space the Celtics would need to absorb the kind of salary necessary in single-team deals to get Boston out of being a second (and perhaps even first) apron ball club. There are other, more complex ways the Celtics could get cheaper -- and others that would take more time -- but if the Celtics want to get cheaper in a hurry, all roads lead to Brooklyn. Advertisement The cohost of the CLNS Media "Garden Report" podcast, Bobby Manning, sat down with the New York Post's Brian Lewis on a recent episode of the show to talk over the potentiality for a Nets-Celtics cap cleansing team up. Take a look at the clip embedded below to hear what they had to say. If you enjoy this pod, check out the "How Bout Them Celtics," "First to the Floor," and the many other New England sports podcasts available on the CLNS Media network: This article originally appeared on Celtics Wire: How the Brooklyn Nets can help the Celtics this NBA offseason

Baird Lowers Tesla (TSLA) to Hold, Citing Valuation and Robotaxi Risk
Baird Lowers Tesla (TSLA) to Hold, Citing Valuation and Robotaxi Risk

Yahoo

time10 minutes ago

  • Yahoo

Baird Lowers Tesla (TSLA) to Hold, Citing Valuation and Robotaxi Risk

Tesla Inc. (NASDAQ:TSLA) is one of the 10 best tech stocks to buy according to billionaires right now. On June 9, Ben Kallo of Robert W. Baird downgraded Tesla from Buy to Hold mainly on valuation concerns, while keeping his price target unchanged at $320. In his view, much of the recent upside in the stock, up over 20% since Q1 earnings, has already factored in the excitement around Tesla's planned robotaxi service and the prospect of a lower-cost electric vehicle. Hadrian / Kallo cited two key areas of concern behind the downgrade. First, he flagged elevated market expectations ahead of Tesla's upcoming robotaxi event, which he believes could be difficult to meet. Second, he raised questions around 'key-man' risk, pointing to ongoing uncertainty tied to CEO Elon Musk's central role in the company's strategic direction. While Musk has resigned from the Department of Government Efficiency (DOGE), it may still take time for him to recoup investor confidence. While Kallo still considers Tesla a core long-term holding, he expressed skepticism about the near-term ramp-up of the robotaxi program, describing current projections as potentially too ambitious. He also noted that Elon Musk's political affiliations, particularly his perceived alignment with former President Trump, could introduce additional headline and regulatory risk moving forward. Tesla Inc. (NASDAQ:TSLA) is an EV manufacturer and clean energy company known for its innovative approach to sustainable transportation and energy solutions. It designs, manufactures, and sells electric vehicles, battery energy storage systems, solar products, and related services. It currently manufactures five different consumer vehicles: the Model 3, Y, S, X, and the Cybertruck. While we acknowledge the potential of TSLA as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Morgan Stanley Sees 8.8% EPS CAGR for Centene (NYSE:CNC), Initiates Coverage with $70 target.
Morgan Stanley Sees 8.8% EPS CAGR for Centene (NYSE:CNC), Initiates Coverage with $70 target.

Yahoo

time10 minutes ago

  • Yahoo

Morgan Stanley Sees 8.8% EPS CAGR for Centene (NYSE:CNC), Initiates Coverage with $70 target.

Centene Corporation (NYSE:CNC) is one of the 8 cheap beginner stocks to buy right now. On June 9, Morgan Stanley analysts began covering Centene Corporation (NYSE:CNC) with an Overweight rating and a $70 price target. The analysts emphasized Centene's status as a prominent managed care provider, particularly within the Medicare Advantage, Medicaid, and Individual Exchange programs. Centene's robust footprint in the Medicaid market is a significant asset, the analysts pointed out, despite the program's difficulties, which include financing instability and state rate-member acuity mismatch. In order to support long-term growth, they also highlighted possible expansion prospects in the ICHRA market and D-SNP integration. Morgan Stanley also highlighted the possibility of ongoing cost reductions along with faster growth in better margin categories, which might eventually result in margin increase. The firm predicts that over the next three years, these elements combined with capital deployment will sustain an EPS compound annual growth rate of 8.8%. Centene Corporation (NYSE:CNC), headquartered in St. Louis, Missouri, is a managed care company that serves as a middleman between government-sponsored and privately insured healthcare programs. While we acknowledge the potential of CNC as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. Read More: and Disclosure: None. Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store